Direct‐to‐Consumer Advertising and the Demand for Cholesterol‐Reducing Drugs
- 1 October 2002
- journal article
- Published by University of Chicago Press in The Journal of Law and Economics
- Vol. 45 (S2) , 673-690
- https://doi.org/10.1086/374704
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Do Pharmaceutical Sales Respond to Scientific Evidence?Journal of Economics & Management Strategy, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial InfarctionCirculation, 2001
- Pravastatin Therapy and the Risk of StrokeNew England Journal of Medicine, 2000
- Clinical Outcomes in Statin Treatment TrialsArchives of internal medicine (1960), 1999
- Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects Commentary: Dietary change, cholesterol reduction, and the public health---what does meta-analysis add?BMJ, 1998
- Book Review Lipids: Current perspectives Edited by D. John Betteridge. 302 pp. St. Louis, Mosby, 1996. $75. 1-85317-231-6New England Journal of Medicine, 1997
- Automobile Air Bags in the 1990s: Market Failure or Market Efficiency?The Journal of Law and Economics, 1995
- Information, Advertising and Health Choices: A Study of the Cereal MarketThe RAND Journal of Economics, 1990